Lupin Ltd signs licensing deal with Sandoz for Ranibizumab biosimilar (INR 1944.35, -1.80)
StreetAccount Summary - Trading higher/lower: EU mid-morning
Sandoz Group downgraded to neutral from buy at BofA (CHF 50.52, 0.00)
Sandoz Group downgraded to hold from buy at Jefferies (CHF 50.52, 0.00)
StreetAccount Summary: EU stocks reaching new 52-week highs/lows (130 total)
Sandoz Group reports H1 EPS $1.46 ex-items vs FactSet $1.29 [3 est, $1.23-1.32] (CHF 45.24, 0.00)
Powered by FactSet Research Systems Inc.